Prescription monitoring of cardiovascular medications in Dhaka, Bangladesh

Abstract

Coronary heart disease, cerebrovascular illness, peripheral arterial disease, rheumatic heart disease, congenital heart disease,
deep vein thrombosis, pulmonary embolism, and a host of other conditions all fall under the umbrella term "cardiovascular
disease" (CVD).Worldwide, cardiovascular diseases kill more people each year than any other condition. An estimated 17.3
million individuals died from CVDs in 2008, representing 30% of all worldwide fatalities. About 7.3 million of these fatalities
were attributed to heart disease, while another 6.2 million were the result of stroke.Over 80% of fatalities from CVD occur in
poor and medium income nations, and the mortality toll is roughly equal across men and women. Nearly 25 million individuals
will lose their lives to CVDs such heart disease and stroke by the year 2030. These are expected to continue being by far the
most lethal factors. Tobacco use, poor nutrition and obesity, lack of exercise, high blood pressure, diabetes, and high cholesterol
levels are only some of the risk factors for cardiovascular disease that may be mitigated.An estimated 7.5 million fatalities
annually (13% of all deaths) are caused by hypertension. This includes 45% of fatalities from coronary heart disease and 51%
of deaths from strokes. Cardiac specialists and family doctors from Bangladesh's best hospitals and medical schools had their
prescriptions checked. From among 1200 prescriptions evaluated at random from the National Heart Foundation and Dhaka
Medical College Hospital, around 1000 were chosen to be filled outside. In the end, 700 prescriptions were chosen for the
study with the right kind of patient assistance in place. All of them dealt only with heart illness and were given by cardiologists
(99.99 percent) rather than general physicians (0.1 percent). This survey was conducted between January 2012 and August
2012 in the vicinity of the National Heart Foundation and the Dhaka Medical College Hospital in Dhaka, Bangladesh. All of
the patients were above the age of 30, the male to female ratio was 57.14 to 42.86, and 64.28 percent of the patients were from
metropolitan areas, while 35.71 percent were from rural areas. 25.0% were prescribed beta-adrenoceptor blockers, 19.57
percent were given organic nitrates, 10.42 percent were given medications that affect the renin-angiotensin system, 10.40
percent were given medications that reduce cholesterol levels, and 2.85 percent were given medications that treat other
conditions. These findings may provide a new statistical strategy for the efficient treatment of cardiovascular illness in
Bangladesh, as well as guidance for the most effective use of cardiovascular medicines.